5
Nifty Close R1 R2 S1 S2 11278 11465 11565 11232 11100 NIFTY SENSEX BANKNIFTY INDIAVIX 10YR G-SEC USDINR 11,278.00 38,193.92 22,267.00 22.23% 5.98% 73.32 -0.35% -0.45% -2.10% -2.16% -1.11% -0.56% www.inventuregrowth.com Market Insight 10 th September 2020 Nifty Short Term View The Indian stock market is notably lower after a weak start Wednesday morning with investors pressing sales at several counters from across various sectors. Rising tensions between India and China along the border at Ladakh, continued surge in coronavirus cases and news about AstraZeneca pausing a clinical trial of its coronavirus vaccine are weighing on sentiment. Nifty is down 39.35 points at 11,278, after falling to a low of 11,207.50. Nifty open on a negative note but in later half index took support near 50 day SMA and bull manage to pull nifty toward 11300 mark. However, till the time Nifty do not sustain above 20 day SMA which is at 11405 one should be avoid fresh long positions. For the second consecutive month in August, equity schemes of mutual funds reported net outflows as investors pulled money out over concerns arising out of weak economic conditions and in anticipation of fall in the equity markets. Data from the AMFI show that equity funds saw net outflows of Rs 3,999.62 crore in August. Middle East sovereign wealth funds in talks to buy stakes in Reliance Retail: Report. Adia is in discussions about an investment of $750 million at a valuation of roughly $57 billion, according to people familiar with the matter, while the PIF could funnel as much as $1.5 billion into the entity controlled by Reliance Industries. Royal Enfield maker Eicher Motors on Wednesday said it will commence local assembly of its motorcycles in Argentina in partnership with Grupo Simpa, its local distributor in the country since 2018. India has started a probe against dumping of ‘vitamin C’ by China into the country after it received a complaint from Bajaj Healthcare Ltd. Drug firm Zydus Cadila on Wednesday said it has received approval from the US health regulator to market diabetes drug, Empagliflozin and Linagliptin tablets, in the US market. Syngene International Ltd. received ICMR approval for HiMedia-Syngene's COVID-19 antibody test kit, ELI Safe 19. Victory Emerging Markets Small Cap Fund acquired 8,03,003 shares of Escorts Ltd. at Rs 1,165.44 per share on the NSE. IndiaBulls Housing Finance, the country's third-largest home finance player has launched a qualified institutional placement (QIP) with a base size of $60 million and an upsize option of $40 million to bolster its capital base and strengthen its balance sheet, people with knowledge of the matter told Moneycontrol. The country's largest lender State Bank of India (SBI) on Wednesday said it has raised Rs 4,000 crore through the issuance of Basel III compliant debt instruments. The Drug Controller General of India (DCGI) V G Somani has issued a show cause notice to Hindustan Unilever Limited (HUL) over advertisement of Lifebuoy Immunity Boosting Hand Sanitizer, that claims to boost immunity, thereby protecting people from covid contagion. Eveready Industries Q1 results: Net profit up 3-fold to Rs 25 crore. The company had posted a net profit of Rs 6.91 crore in the April-June period a year ago, Eveready Industries said in a regulatory filing. Serum Institute gets DCGI notice over Oxford COVID-19 vaccine trial suspension by AstraZeneca abroad. News Buzz

NIFTY SENSEX BANKNIFTY INDIAVIX 10YR G-SEC USDINR

  • Upload
    others

  • View
    11

  • Download
    0

Embed Size (px)

Citation preview

Page 1: NIFTY SENSEX BANKNIFTY INDIAVIX 10YR G-SEC USDINR

Nifty Close R1 R2 S1 S2

11278 11465 11565 11232 11100

NIFTY SENSEX BANKNIFTY INDIAVIX 10YR G-SEC USDINR

11,278.00 38,193.92 22,267.00 22.23% 5.98% 73.32

-0.35% -0.45% -2.10% -2.16% -1.11% -0.56%

www.inventuregrowth.com

Market Insight 10th September 2020

Nifty Short Term View

The Indian stock market is notably lower after a weakstart Wednesday morning with investors pressing salesat several counters from across various sectors. Risingtensions between India and China along the border atLadakh, continued surge in coronavirus cases and newsabout AstraZeneca pausing a clinical trial of itscoronavirus vaccine are weighing on sentiment. Nifty isdown 39.35 points at 11,278, after falling to a low of11,207.50.

Nifty open on a negative note but in later half indextook support near 50 day SMA and bull manage to pullnifty toward 11300 mark. However, till the time Niftydo not sustain above 20 day SMA which is at 11405one should be avoid fresh long positions.

• For the second consecutive month in August, equity schemes of mutual funds reported net outflows as investors pulledmoney out over concerns arising out of weak economic conditions and in anticipation of fall in the equity markets. Datafrom the AMFI show that equity funds saw net outflows of Rs 3,999.62 crore in August.

• Middle East sovereign wealth funds in talks to buy stakes in Reliance Retail: Report. Adia is in discussions about aninvestment of $750 million at a valuation of roughly $57 billion, according to people familiar with the matter, while thePIF could funnel as much as $1.5 billion into the entity controlled by Reliance Industries.

• Royal Enfield maker Eicher Motors on Wednesday said it will commence local assembly of its motorcycles in Argentinain partnership with Grupo Simpa, its local distributor in the country since 2018.

• India has started a probe against dumping of ‘vitamin C’ by China into the country after it received a complaint fromBajaj Healthcare Ltd.

• Drug firm Zydus Cadila on Wednesday said it has received approval from the US health regulator to market diabetesdrug, Empagliflozin and Linagliptin tablets, in the US market.

• Syngene International Ltd. received ICMR approval for HiMedia-Syngene's COVID-19 antibody test kit, ELI Safe 19.• Victory Emerging Markets Small Cap Fund acquired 8,03,003 shares of Escorts Ltd. at Rs 1,165.44 per share on the NSE.• IndiaBulls Housing Finance, the country's third-largest home finance player has launched a qualified institutional

placement (QIP) with a base size of $60 million and an upsize option of $40 million to bolster its capital base andstrengthen its balance sheet, people with knowledge of the matter told Moneycontrol.

• The country's largest lender State Bank of India (SBI) on Wednesday said it has raised Rs 4,000 crore through theissuance of Basel III compliant debt instruments.

• The Drug Controller General of India (DCGI) V G Somani has issued a show cause notice to Hindustan Unilever Limited(HUL) over advertisement of Lifebuoy Immunity Boosting Hand Sanitizer, that claims to boost immunity, therebyprotecting people from covid contagion.

• Eveready Industries Q1 results: Net profit up 3-fold to Rs 25 crore. The company had posted a net profit of Rs 6.91 crorein the April-June period a year ago, Eveready Industries said in a regulatory filing.

• Serum Institute gets DCGI notice over Oxford COVID-19 vaccine trial suspension by AstraZeneca abroad.

News Buzz

Page 2: NIFTY SENSEX BANKNIFTY INDIAVIX 10YR G-SEC USDINR

www.inventuregrowth.com

1.3

1.8 8.

2

3.3 16

.2

50.3 65

.1 82.4

65.3

43.7

39.2

31.7

30.8

89.2

47.8 61

.2

47.1

22.6

27.2

13.0

6.0

1.8

-

20

40

60

80

100

Tho

usa

nd

s C

on

trac

ts

CE

PE

0.0

0.1

0.6

1.3 8.

5

25.3

13.3

8.0

-2.0

-5.8

-12.

5-4.7 -0

.9

4.1 10

.0

14.1

-8.0

-6.6 -1

.2

-0.6

-0.3

-0.2

(20)

(10)

-

10

20

30

Tho

usa

nd

s C

on

trac

ts

CE

PE

OI

OI Change

Client51.9%

DII7.6%

FII29.6%

Pro10.8%

50.9%

26.1%

54.8%

49.5%

49.1%

73.9%

45.2%

50.5%

Client

DII

FII

Pro

Future Index Long Future Index Short

Participant wise OI Activity ( Fig in ‘000 Contracts) Index Future OI %

Participant Type

Index Fut Activity

Call Activity

Put Activity

Retail 6.3 69.0 -8.4

DII 6.4 0.0 0.0

FII -10.1 -6.0 21.9

Pro -2.6 -63.0 -13.4

Index NIFTY Change

Fut Closing 11306.9 -0.1%

Prem /Disc 28.90 26.40

OI Qty 1.06 Cr. -5.2%

Nifty PCR 1.01

Highest OI 11500 CE 11000 PE

• Yesterday, FII had added Short 10.1K Contracts in Index Futures and Clients had done Short Covering of 6.3K Contracts

• FII had added Call Short by 6K Contracts and added Put Long by 21.9K Contracts

• Clients had added Call Long by 69K Contracts and added Put Short by 8.4K Contracts

Index BANKNIFTY Change

Fut Closing 22337.25 -1.8%

Prem/Disc 70.25 65.80

OI Qty 0.17 Cr. 4.1%

Highest OI 24000 CE 22000 PE

• Nifty Bank future was Down 1.81% with increase in O Iby 4.06%.

• Nifty Bank Put O I addition was seen at 22000 followedby 20000 which can act as short term support.

• Nifty Bank Call O I addition was seen at 22500 followedby 23000 which can act as short term resistance.

0.8

0.3 1.8

1.3 2

0.6 5

9.0 9

7.0

65

.6 81

.9

38

.8

48

.0

42

.3

24

.3 48

.1

47

.4 69

.7

34

.1

23

.9

12

.8

10

.2

2.9 3.6

-

50

100

150

Tho

usa

nd

s C

on

trac

ts

CE

PE

-0.1

0.1

-0.5

0.4

17.8

48.7

36.6

3.9 13

.4

-2.6

-3.7

11.9

4.3

6.2 10

.3

22.2

-7.6

-13.

6 -3.0

-1.3

-0.1

-0.3 (20)

-

20

40

60

Tho

usa

nd

s C

on

trac

ts CE

PE

OI

OI Change

Derivative Activity

• NIFTY future was Down 0.11% with decrease in O I by5.22%.

• Nifty Put O I addition was seen at 11200 followed by11100 which can act as short term support

• Nifty Call O I addition was seen at 11300 followed by11400. which can act as short term resistance

Page 3: NIFTY SENSEX BANKNIFTY INDIAVIX 10YR G-SEC USDINR

Stock Future & Option Activity

Open Interest Gainers

Symbol Trend Future Price

Price Chng%

Fut OI Chng %

IDFCFIRSTB Down 29.3 -2.5% 17.5%

APOLLOHOSP Down 1610.6 -1.6% 15.9%

SUNTV Down 467.25 -1.5% 12.3%

CONCOR Down 374.2 -2.9% 10.5%

RBLBANK Down 175.8 -1.6% 10.0%

Open interest Losers

Symbol Trend Future Price

Price Chng %

Fut OI Chng %

EXIDEIND Down 156.35 -1.2% -6.8%

BHEL Down 36.35 -2.8% -6.6%

BANKBARODA Down 44.55 -1.7% -5.7%

NMDC Down 92.1 2.3% -4.8%

HDFCLIFE Down 588.5 0.9% -4.3%

Volume Gainers

Symbol Trend Future Price

Price Chng%

3 Day VolChng %

ESCORTS Up 1205.2 7.1% 104.0%

VEDL Up 128.6 2.3% 68.3%

TATASTEEL Down 419.6 3.4% 67.3%

BAJAJFINSV Neutral 6058.5 -2.8% 56.7%

ONGC Down 73.05 -2.1% 50.7%

Highest Position Carry forward %

Symbol Trend Future Price

Price Chng%

O I Chng / Volume

IDFCFIRSTB Down 29.3 -2.5% 22.5%

VEDL Up 128.6 2.3% 17.6%

COLPAL Down 1372.75 0.6% 17.4%

SUNTV Down 467.25 -1.5% 15.8%

CONCOR Down 374.2 -2.9% 15.0%

Stocks Near Highest Call Open Interest

Symbol Trend Future Price

Highest Call OI

No of Contracts

BATAINDIA Up 1288.6 1400 1029

HDFC Down 1765.35 1900 3259

M&MFIN Down 130.55 150 1023

Stocks Near Highest Put Open Interest

Symbol Trend Future Price

Highest Put OI

No of Contracts

HDFC Down 1765.35 1750 1427

AUROPHARMA Down 806.05 800 398

BANKBARODA Down 44.55 45 393

www.inventuregrowth.com

BAN Scripts - > BANKBARODA: 92%, BHEL: 101%, CANBK: 82%, IBULHSGFIN: 91%, IDEA: 84%, JINDALSTEL: 92%, PNB: 82%

Page 4: NIFTY SENSEX BANKNIFTY INDIAVIX 10YR G-SEC USDINR

www.inventuregrowth.com

Symbol Close Trend 5 Day SMA 10 Day SMA 20 Day SMA R3 R2 R1 S1 S2 S3

NIFTY 11278 Neutral 11377.4 11461.7 11419.3 11474.2 11399.3 11324.3 11231.7 11156.7 11081.8

BANKNIFTY 22267 Down 22924.7 23434.4 22900.0 22797.0 22594.5 22392.1 22141.9 21939.5 21737.0

ADANIPORTS 343.85 Up 353.3 355.0 354.0 352.7 349.3 345.9 341.8 338.4 335.0

ASIANPAINT 1979.05 Up 1978.7 1970.4 1934.5 2021.0 2005.0 1989.0 1969.1 1953.1 1937.1

AXISBANK 431.25 Down 454.6 473.2 459.5 447.7 441.4 435.1 427.4 421.1 414.8

BAJAJ-AUTO 2910.4 Down 2910.4 2948.2 3002.1 2977.3 2951.8 2926.2 2894.6 2869.0 2843.5

BAJAJFINSV 6026.8 Neutral 6249.6 6335.6 6354.0 6231.1 6153.1 6075.0 5978.6 5900.5 5822.5

BAJFINANCE 3422.9 Up 3527.6 3572.3 3513.4 3549.5 3501.2 3452.8 3393.0 3344.6 3296.3

BHARTIARTL 504.25 Down 518.6 524.7 526.0 517.1 512.2 507.3 501.2 496.3 491.4

BPCL 405.95 Down 408.3 410.7 410.9 418.6 413.8 408.9 403.0 398.1 393.3

BRITANNIA 3738.35 Down 3743.0 3769.3 3791.7 3830.7 3795.4 3760.1 3716.6 3681.3 3646.0

CIPLA 727.55 Down 726.1 734.2 748.1 744.1 737.8 731.5 723.6 717.3 711.0

COALINDIA 126.95 Down 131.8 134.6 135.9 129.8 128.7 127.6 126.3 125.2 124.1

DRREDDY 4429.45 Down 4400.7 4388.5 4444.3 4514.9 4482.3 4449.6 4409.3 4376.6 4344.0

EICHERMOT 2177 Down 2195.0 2187.0 8876.8 2239.3 2215.5 2191.7 2162.3 2138.5 2114.7

GAIL 91.05 Down 95.8 96.9 98.2 93.4 92.5 91.6 90.5 89.6 88.7

GRASIM 687.05 Up 702.1 694.7 675.1 706.2 698.9 691.6 682.5 675.2 667.9

HCLTECH 721.95 Down 712.7 707.5 710.3 739.0 732.5 726.0 717.9 711.4 704.9

HDFC 1760.75 Down 1788.2 1824.1 1819.6 1808.5 1790.2 1772.0 1749.5 1731.3 1713.0

HDFCBANK 1096.5 Up 1111.2 1115.2 1094.1 1120.5 1111.3 1102.2 1090.8 1081.7 1072.5

HDFCLIFE 585.7 Down 585.3 586.4 592.1 603.2 596.5 589.8 581.6 574.9 568.2

HEROMOTOCO 2903.95 Neutral 2906.3 2974.8 2966.1 2982.4 2952.4 2922.5 2885.4 2855.5 2825.5

HINDALCO 182.8 Down 186.6 189.7 191.4 189.0 186.6 184.3 181.3 179.0 176.6

HINDUNILVR 2132.25 Down 2147.1 2153.5 2175.1 2175.5 2159.0 2142.5 2122.0 2105.5 2089.0

ICICIBANK 367.6 Down 376.0 386.7 380.1 379.3 374.8 370.4 364.8 360.4 355.9

INDUSINDBK 604.65 Up 613.8 625.3 575.5 634.3 623.0 611.6 597.7 586.3 575.0

INFRATEL 210.45 Up 217.6 207.7 204.0 218.7 215.5 212.4 208.5 205.4 202.2

INFY 927.75 Down 931.9 933.1 944.5 950.2 941.6 933.0 922.5 913.9 905.3

IOC 80.55 Down 83.5 85.1 86.5 82.3 81.7 81.0 80.1 79.4 78.8

ITC 183.8 Down 188.6 190.9 194.4 187.9 186.3 184.8 182.8 181.3 179.7

JSWSTEEL 286.85 Up 286.8 285.9 281.7 295.8 292.4 289.0 284.7 281.3 277.9

KOTAKBANK 1326.15 Down 1364.9 1395.6 1376.6 1363.3 1349.1 1334.9 1317.4 1303.2 1289.0

LT 909.5 Down 935.4 951.6 972.9 930.7 922.6 914.5 904.5 896.4 888.3

M&M 613.9 Up 623.9 625.7 621.8 630.5 624.1 617.8 610.0 603.7 597.3

MARUTI 7215.25 Up 7206.5 7105.2 7008.9 7412.9 7337.4 7261.9 7168.6 7093.1 7017.6

NESTLEIND 16312.5 Down 16333.3 16245.0 16340.4 16655.1 16524.2 16393.3 16231.7 16100.8 15969.9

NTPC 90.4 Down 93.7 97.0 97.6 92.3 91.6 90.8 90.0 89.2 88.5

ONGC 72.7 Down 76.4 78.5 79.5 74.9 74.0 73.2 72.2 71.4 70.5

POWERGRID 175.25 Down 176.5 177.9 179.7 178.7 177.4 176.1 174.4 173.1 171.8

RELIANCE 2161.35 Up 2117.0 2115.8 2114.6 2219.1 2197.0 2175.0 2147.7 2125.7 2103.6

SBIN 194.85 Down 205.9 212.0 206.0 200.4 198.3 196.2 193.5 191.4 189.3

SHREECEM 19401.25 Down 19885.2 20414.8 21150.0 19853.3 19680.6 19507.9 19294.6 19121.9 18949.2

SUNPHARMA 509.3 Down 514.3 522.8 525.4 521.5 516.9 512.2 506.4 501.7 497.1

TATAMOTORS 140.1 Up 146.8 146.1 136.1 145.4 143.4 141.3 138.9 136.8 134.8

TATASTEEL 417.4 Down 422.6 425.6 426.4 429.6 425.0 420.3 414.5 409.8 405.2

TCS 2327.55 Up 2324.6 2292.4 2275.2 2375.5 2357.2 2338.9 2316.2 2297.9 2279.6

TECHM 753.35 Up 753.9 747.5 734.3 771.9 764.8 757.7 749.0 741.9 734.8

TITAN 1161.1 Up 1170.2 1149.0 1138.4 1191.3 1179.8 1168.2 1154.0 1142.4 1130.9

ULTRACEMCO 3835.1 Down 3885.7 3939.1 4032.6 3927.5 3892.2 3856.9 3813.3 3778.0 3742.7

UPL 494.55 Down 503.0 505.3 498.6 510.2 504.2 498.2 490.9 484.9 478.9

WIPRO 282.85 Up 281.4 277.4 277.2 289.4 286.9 284.4 281.3 278.8 276.3

ZEEL 221.55 Up 220.1 215.1 201.2 231.6 227.8 223.9 219.2 215.3 211.5

Nifty 50 Daily Levels

Page 5: NIFTY SENSEX BANKNIFTY INDIAVIX 10YR G-SEC USDINR

Created by: IGSL - ResearchInventure Growth & Securities Ltd,201,Viraj Tower, Near Landmark Building,Western Express Highway, Andheri (East),Mumbai -400 093Tele: 91-22-71148500 , Fax: 91-22-40751511.E-mail: [email protected] , website : http://www.inventuregrowth.com

Research Team Tel: 022 – 71148579 E-mail: research@inventuregrowthcom Website: Inventuregrowth.com

Research Team Profile Email ID

Mr. Prashant Barwaliya Head- Research [email protected]

Mr. Virat Jagad Technical Analyst [email protected]

Ms. Jeni Rita Fundamental Analyst [email protected]

Ms. Darshita Shah Fundamental Analyst [email protected]

This Report is published by Inventure Growth & Securities Limited (hereinafter referred to as “IGSL”) for private circulation. IGSL is a registered Research Analyst underSEBI (Research Analyst) Regulations, 2014 having Registration no. INH000006129. IGSL is also a registered Stock Broker with National Stock Exchange of India Limited,BSE Limited and Metropolitan Stock Exchange of India Limited (MSE) in cash, F&O & currency derivatives segments. It is also registered as a Depository Participantwith CDSL and is also registered with AMFI as a Mutual Fund Distributor

IGSL have not been debarred / suspended by SEBI for Retail & Institutional business or any other regulatory authority for accessing / dealing in securities Market otherthan PRO business. IGSL, its associates or analyst or his relatives may or may not hold any financial interest in the subject company. IGSL or its associates or Analyst donot have any conflict or material conflict of interest at the time of publication of the research report with the subject company. IGSL or its Affiliates may or may nothave been beneficial ownership of one percent or more of the securities mentioned in this report. However, one or more of IGSL or its Affiliates may, from time totime, have a long or short position in any of the securities mentioned herein and may buy or sell those securities or options thereon, either on their own account.

IGSL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst duringthe past twelve months. IGSL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connectionwith the research report. Analyst has not served as an officer, director or employee of Subject Company and IGSL / analyst has not been engaged in market makingactivity of the subject company.

Analyst Certification: I/We, Virat Jagad the research analyst Is the author of this report, hereby certify that the views expressed in this research report accuratelyreflects my/our personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of theanalyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s) principally responsiblefor the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations.

DISCLAIMERInventure Growth and Securities Limited (hereinafter referred to as “IGSL”) is a registered Member of National Stock Exchange of India Limited, Bombay StockExchange Limited and Metropolitan Stock Exchange Limited. It is also registered as a Depository Participant with CDSL. It also has registration with AMFI as a MutualFund Distributor. Inventure Growth and Securities Limited is a registered entity with SEBI for Research Analyst in terms of SEBI (Research Analyst) Regulations, 2014vide registration number INH000006129. IGSL has not been debarred/ suspended by SEBI or any other regulatory authority for accessing /dealing in securities Market.IGSL or its associates/ analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during thepast twelve months.

This document is solely for the personal information of the recipient, and must not be singularly used as the basis of any investment decision. Nothing in this documentshould be construed as investment or financial advice. Each recipient of this document should make such investigations as they deem necessary to arrive at anindependent evaluation of an investment in the securities of the companies referred to in this document (including the merits and risks involved), and should consulttheir own advisors to determine the merits and risks of such an investment. Reports based on technical and derivative analysis center on studying charts of a stock'sprice movement, outstanding positions and trading volume, as opposed to focusing on a company's fundamentals and, as such, may not match with a report on acompany's fundamentals. Investors are advised to refer the Fundamental and Technical Research Reports available on our website to evaluate the contrary view, ifany.

The information in this document has been printed on the basis of publicly available information, internal data and other reliable sources believed to be true, but wedo not represent that it is accurate or complete and it should not be relied on as such, as this document is for general guidance only. Inventure Growth and SecuritiesLimited or any of its affiliates/ group companies shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error inthe information contained in this report. Inventure Growth and Securities Limited has not independently verified all the information contained within this document.Accordingly, we cannot testify, nor make any representation or warranty, express or implied, to the accuracy, contents or data contained within this document. WhileInventure Growth and Securities Limited endeavors to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance,or other reasons that prevent us from doing so. This document is being supplied to you solely for your information, and its contents, information or data may not bereproduced, redistributed or passed on, directly or indirectly.

Neither Inventure Growth and Securities Limited , nor its directors, employees or affiliates shall be liable for any loss or damage that may arise from or in connectionwith the use of this information.

http://www.inventuregrowth.com/

DISCLOSURES